Pune court rejects trademark-violation plea against Serum Institute over `Covishield`

On January 4, Cutis-Biotech, a pharmacertical firm, filed a suit in the civil court claiming it was a prior user of the brandname Covishield, and sought to restrain SII from using the name. SII is producing a coronavirus vaccine named Covishield, co-developed by the University of Oxford and British-Swedish company AstraZeneca.

https://ift.tt/eA8V8J from https://ift.tt/2MG8NJD